Tag: Drug shortages

The Food and Drug Administration has officially announced the end of the shortage of Novo Nordisk’s popular drug semaglutide, a development that has significant implications for both patients and the pharmaceutical industry. This drug,...

Novo Nordisk’s Obesity Trial Disappoints Novo Nordisk, a key player in the pharmaceutical industry, recently faced a setback with their next-generation obesity candidate, CagriSema. The pivotal study results showed that the treatment helped patients lose...